| Title | Authors / Editors | Date |
unige:101428 |
Women, thrombosis, and cancer: A gender-specific analysis |
Farge, Dominique; Bounameaux, Henri; Bauersachs, Rupert M; Brenner, Benjamin |
2017 |
unige:27462 |
Vorapaxar in Patients with Peripheral Artery Disease: Results from TRA2{degrees}P-TIMI 50 |
Bonaca, Marc P; Scirica, Benjamin M; Creager, Mark A; Olin, Jeffrey W; ... Morrow, David A |
2013 |
unige:23982 |
Venous thromboembolism: why does ethnicity matter? |
Bounameaux, Henri; Rosendaal, Frits R |
2011 |
unige:1839 |
Venous thromboembolism: contemporary diagnostic and therapeutic aspects |
Bounameaux, Henri; Righini, Marc Philip; Perrier, Arnaud |
2008 |
unige:73872 |
Venous thromboembolism diagnosis: unresolved issues |
Righini, Marc Philip; Le Gal, G; Bounameaux, Henri |
2015 |
unige:7976 |
Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome |
Nendaz, Mathieu; Bandelier, Patrick Jérôme; Aujesky, Drahomir; Cornuz, Jacques; ... Perrier, Arnaud |
2004 |
unige:133080 |
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry |
Ageno, Walter; Haas, Sylvia; Weitz, Jeffrey I; Goldhaber, Samuel Z; ... Kakkar, Ajay K |
2019 |
unige:111242 |
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper |
Abraham, Paul Samuel; Arroyo, Diego A; Giraud, Raphaël; Bounameaux, Henri; Bendjelid, Karim |
2018 |
unige:75136 |
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study |
Weitz, J I; Bauersachs, R; Beyer-Westendorf, J; Bounameaux, Henri; ... Prandoni, P |
2015 |
unige:19686 |
Treatment strategies for acute pulmonary embolism |
Blondon, Marc; Bounameaux, Henri; Righini, Marc Philip |
2009 |
unige:86256 |
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies |
Di Nisio, Marcello; Vedovati, Maria C; Riera-Mestre, Antoni; Prins, Martin H; ... Lensing, Anthonie W A |
2016 |
unige:20932 |
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study |
Fiessinger, J. N.; Bounameaux, Henri; Cairols, M. A.; Clement, D. L.; ... Turpie, A G. G. |
2010 |
unige:26320 |
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology |
Méan, Marie; Righini, Marc Philip; Jaeger, Kurt; Beer, Hans-Jürg; ... Aujesky, Drahomir |
2013 |
unige:23981 |
The pulmonary embolism rule-out criteria (PERC) rule does not safely exclude pulmonary embolism |
Hugli, O; Righini, Marc Philip; Le Gal, G; Roy, P-M; ... Aujesky, D |
2011 |
unige:23976 |
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism |
Mavrakanas, Thomas; Bounameaux, Henri |
2011 |
unige:19505 |
The novel anticoagulants: entering a new era |
Bounameaux, Henri |
2009 |
unige:23987 |
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin |
Fontana, Pierre; Alberts, P; Sakariassen, K S; Bounameaux, Henri; ... Santana Sorensen, A |
2011 |
unige:26370 |
Symptoms and clinical relevance: A dilemma for clinical trials on prevention of venous thromboembolism |
Bounameaux, Henri; Agnelli, Giancarlo |
2013 |
unige:19514 |
Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study |
Chopard, Pierre; Spirk, David; Beer, Hans-Jurg; Peter, Jurg; ... Dorfller-Melly, Janine |
2009 |
unige:20439 |
Stenting carotidien: place de l'evidence-based medicine! |
Bounameaux, Henri; De Moerloose, Philippe; Mazzolai, L. |
2010 |